Morpho Biotech and MACHEREY-NAGEL Announce Distribution Agreement for The Netherlands
May 16, 2025
Morpho Biotech announces it has signed a distribution agreement with MACHEREY-NAGEL (MN) to distribute their Bioanalysis portfolio in the Netherlands as of July 1st. MN is an innovative international company for chemical and biomolecular analysis. The Bioanalysis portfolio of MN consists of efficient and reliable kits for RNA, DNA and protein purification from various sample [...]
Agilent Partners Ubix Therapeutics to Advance Transformative Cancer Research in South Korea
May 15, 2025
Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes SEOUL, South Korea -- Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over [...]
May 15, 2025
First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research Fremont, California. Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAseq™ CNS Disease Panel 120 to include novel assays for brain-derived phosphorylated tau (pTau) proteins. The enhanced panel now [...]
May 15, 2025
N of 1 therapy uniquely developed, on demand, for infant with life-threatening rare metabolic disorder in six months Results published in The New England Journal of Medicine and showcased at American Society of Gene & Cell Therapy Annual Meeting Fargo, ND and Coralville, IA — Aldevron, a global leader in the production of DNA, RNA [...]
Element Biosciences Welcomes Dr. Madhuri Hegde to its Board of Directors
May 15, 2025
SAN DIEGO – Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced that Madhuri Hegde, Ph.D., has joined its board of directors. Dr. Hegde currently serves as senior vice president and Chief Scientific Officer at Revvity, Inc., where she leads the strategic scientific direction of the company. A board-certified diplomate in clinical molecular [...]
IMU Biosciences Adopts Curiox’s Pluto for Large-Scale UK Immune Profiling Initiative
May 15, 2025
Leading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping Project Based on UK Patient Big Data SEOUL, South Korea — Curiox Biosystems Co., Ltd. (“Curiox”) announced on March 28 that it has officially received a Sales Order for its Pluto Workstation (“Pluto”) from IMU Biosciences (“IMU”), a UK based techbio company [...]
May 15, 2025
X-Rite Incorporated, a global leader in color science and technology, today announced the launch of the CiF3200 imaging spectrophotometer, designed for color measurement of small, odd-shaped, multi-colored, and highly reflective items. With a minimum measurement area of just 2mm, the CiF3200 allows manufacturers to set and communicate digital color standards for small components, improving [...]
PI Health Sciences Announces Strategic Collaboration with Cresset
May 15, 2025
Mumbai, India – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and a wholly owned subsidiary of PI Industries, today announced a strategic collaboration with Cresset® to implement Torx® Software, a state-of-the-art cloud-based platform for small molecule drug discovery. This partnership marks a significant step in PI Health Sciences’ [...]
May 14, 2025
SAN DIEGO -- Today, TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization devoted to and the discovery, development and delivery of vaccines for global health signed a Memorandum of Understanding to collaborate to advance the research and [...]
BUCHI Acquires NeoSpectra Platform
May 14, 2025
BUCHI acquires Si-Ware Systems’ NeoSpectra Platform to establish a fully integrated quality assurance ecosystem based on NIR. BUCHI sets a new standard in material analysis, offering tailored solutions for quality assurance at key stages of the supply chain in food, feed, and chemicals industries Flawil, Switzerland – BÜCHI Labortechnik AG announces the acquisition of Si-Ware [...]

